| The methods and outcomes of cultural adaptations of psychological treatments for depressive disorders: a systematic review N Chowdhary, AT Jotheeswaran, A Nadkarni, SD Hollon, M King, ... Psychological medicine 44 (6), 1131-1146, 2014 | 366 | 2014 |
| Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders R Colah, A Gorakshakar, A Nadkarni Expert Review of Hematology 3 (1), 103-117, 2010 | 252 | 2010 |
| Effect of Proinflammatory Cytokines (IL‐6, TNF‐α, and IL‐1β) on Clinical Manifestations in Indian SLE Patients V Umare, V Pradhan, M Nadkar, A Rajadhyaksha, M Patwardhan, ... Mediators of inflammation 2014 (1), 385297, 2014 | 169 | 2014 |
| Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview AK Chaudhary, S Pandya, K Ghosh, A Nadkarni Mutation Research/Reviews in Mutation Research 753 (1), 7-23, 2013 | 140 | 2013 |
| HPLC studies in hemoglobinopathies RB Colah, R Surve, P Sawant, E D’souza, K Italia, S Phanasgaonkar, ... The Indian Journal of Pediatrics 74, 657-662, 2007 | 131 | 2007 |
| Hydroxyurea in sickle cell disease—a study of clinico-pharmacological efficacy in the Indian haplotype K Italia, D Jain, S Gattani, F Jijina, A Nadkarni, P Sawant, S Nair, ... Blood Cells, Molecules, and Diseases 42 (1), 25-31, 2009 | 102 | 2009 |
| Response to hydroxyurea in β thalassemia major and intermedia: experience in western India KY Italia, FJ Jijina, R Merchant, S Panjwani, AH Nadkarni, PM Sawant, ... Clinica Chimica Acta 407 (1-2), 10-15, 2009 | 97 | 2009 |
| Epidemiology of β‐thalassaemia in Western India: mapping the frequencies and mutations in sub‐regions of Maharashtra and Gujarat R Colah, A Gorakshakar, S Phanasgaonkar, E D’Souza, A Nadkarni, ... British journal of haematology 149 (5), 739-747, 2010 | 86 | 2010 |
| Regional heterogeneity of β-thalassemia mutations in the multi ethnic Indian population R Colah, A Gorakshakar, A Nadkarni, S Phanasgaonkar, R Surve, ... Blood Cells, Molecules, and Diseases 42 (3), 241-246, 2009 | 84 | 2009 |
| Application of covalent reverse dot blot hybridization for rapid prenatal diagnosis of the common Indian thalassemia syndromes RB Colah, AC Gorakshakar, CY Lu, AH Nadkarni, SN Desai, AR Pawar, ... Ind J Hematol Blood Transf 15 (1), 10-13, 1997 | 74 | 1997 |
| Molecular pathogenesis and clinical variability of β‐thalassemia syndromes among Indians A Nadkarni, AC Gorakshakar, CY Lu, R Krishnamoorthy, K Ghosh, ... American journal of hematology 68 (2), 75-80, 2001 | 71 | 2001 |
| Prevalence and molecular characterization of α-thalassemia syndromes among Indians A Nadkarni, S Phanasgaonkar, R Colah, D Mohanty, K Ghosh Genetic testing 12 (2), 177-180, 2008 | 63 | 2008 |
| Invasive & non-invasive approaches for prenatal diagnosis of haemoglobinopathies: experiences from India RB Colah, AC Gorakshakar, AH Nadkarni Indian Journal of Medical Research 134 (4), 552-560, 2011 | 62 | 2011 |
| Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India MB Mukherjee, AH Nadkarni, AC Gorakshakar, K Ghosh, D Mohanty, ... Indian journal of human genetics 16 (3), 154, 2010 | 53 | 2010 |
| Newborn screening shows a high incidence of sickle cell anemia in Central India DL Jain, V Sarathi, D Upadhye, R Gulhane, AH Nadkarni, K Ghosh, ... Hemoglobin 36 (4), 316-322, 2012 | 52 | 2012 |
| Neonatal screening and the clinical outcome in children with sickle cell disease in central India DS Upadhye, DL Jain, YL Trivedi, AH Nadkarni, K Ghosh, RB Colah PLoS One 11 (1), e0147081, 2016 | 49 | 2016 |
| Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India R Colah, A Nadkarni, A Gorakshakar, S Phanasgaonkar, R Surve, ... Blood Cells, Molecules, and Diseases 33 (2), 153-157, 2004 | 46 | 2004 |
| Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-β-thalassaemia: a genotypic and phenotypic study KY Italia, FF Jijina, R Merchant, S Panjwani, AH Nadkarni, PM Sawant, ... Journal of clinical pathology 63 (2), 147-150, 2010 | 45 | 2010 |
| Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients? V Umare, A Nadkarni, M Nadkar, A Rajadhyksha, P Khadilkar, K Ghosh, ... Journal of postgraduate medicine 63 (2), 92-95, 2017 | 36 | 2017 |
| Borderline HbA2 levels: dilemma in diagnosis of beta-thalassemia carriers S Colaco, A Nadkarni Mutation Research/Reviews in Mutation Research 788, 108387, 2021 | 29 | 2021 |